BRCA1 and ovarian carcinoma: A large genome-wide association study (GWAS) and meta-analysis of sporadic epithelial ovarian cancer cases (15,437), BRCA1 and BRCA2 carriers (15,252 and 8211 respectively) and 30,845 healthy controls identified genomic variants of Wnt pathway components, Wnt4 and RSPO1 genes, as new susceptibility loci [60].